Exelixis Inc
$56.89
USD
Last updated on --.
24h volume2.41M
24h highest56.9700 USD
24h lowest54.7500 USD
24h Price movement+4.12%
EXEL recent prices
24 Hours
+4.12%+$2.250
30 days
+0.72%+$0.395
60 days
-2.52%-$1.405
90 days
+5.65%+$2.965
Key data
Previous close54.6400 USD
Market cap13.49B USD
Volume2.41M
P/E ratio15.680000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)3.4700 USD
Net income (FY)860.62M USD
Revenue (FY)2.44B USD
Last report dateAug 5, 2026
About Exelixis Inc
HeadquartersALAMEDA
Employees (FY)1.08K
Revenue per employee (FY)2.26M USD
Net income per employee (FY)799.09K USD
Listed onNasdaq
EXEL conversion tables
 |  |
|---|---|
| 0.5 EXEL | 28.44 USD |
| 1 EXEL | 56.89 USD |
| 5 EXEL | 284.45 USD |
| 10 EXEL | 568.9 USD |
| |
|---|---|
| 0.5 USD | 0.0087889 EXEL |
| 1 USD | 0.017578 EXEL |
| 5 USD | 0.087889 EXEL |
| 10 USD | 0.17578 EXEL |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
EXEL is trading at $56.89, +4.12% over the last 24 hours. Track live moves on the price chart at the top of this page.
The EXEL stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. EXEL is currently trading at $56.89, +4.12% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on EXEL price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. EXEL's P/E ratio is currently 15.680000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from EXEL; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against EXEL's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Exelixis Inc's market cap is currently 13.49B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume2.41M
24h highest56.9700 USD
24h lowest54.7500 USD
24h Price movement+4.12%
Start trade with EXEL Perpetual
Sign up to trade